Authors
Yujia Hou, Soroush Fariman, Matthew R Dunn, Ilona Fridman, Regina Jones, Jacob N Stein, Samantha Tam, William A Wood, Christine Neslund-Dudas, Jennifer Elston Lafata
Published in
Telemedicine journal and e-health : the official journal of the American Telemedicine Association. Pages 15305627261487924. Sep 11, 2026. Epub Sep 11, 2026.
Abstract
Evidence is limited on how patient-reported symptoms relate to telehealth use and whether telehealth visits yield comparable symptom outcomes to in-person care in routine oncology practice.
An observational cohort of adult patients who received cancer treatment 6 months to 3 years prior to a scheduled oncology visit across two academic medical centers and their affiliated community sites in North Carolina and Michigan was recruited. Pre- and postvisit telephone surveys were linked to electronic health records and geocoded data. Surveys assessed being offered a telehealth visit option and six symptoms (fatigue, pain, insomnia, anxiety, sadness, and discouragement). Chi-square tests were used to compare patient-reported symptoms by visit modality, and logistic regression was used to examine symptom associations with being offered and accepting telehealth visits. Propensity score-weighted changes in symptom composite scores pre- to postvisit were compared by visit modality.
Among 610 patients (496 in-person and 114 telehealth visits), symptoms were common (fatigue 79.7%, pain 73.9%, insomnia 65.9%, anxiety 62.5%, sadness 64.4%, and discouragement 35.1%). A telehealth visit option was offered to 24.8% of patients, among whom 66.2% accepted it. Patients reporting sadness were less likely to be offered a telehealth visit than those without sadness (22.1% vs. 29.5%; p = 0.04) and, if offered, were less likely to accept a telehealth visit (59.8% vs. 75.0%; p = 0.03). In contrast, patients reporting pain were more likely to be offered telehealth than those without pain (26.6% vs. 19.5%; p = 0.04). Changes in composite symptom scores from pre- to postvisit were small and not statistically significant for either in-person (95% confidence interval [CI]: -0.05, 0.01) or telehealth visits (95% CI: -0.12, 0.05).
Although access to telehealth oncology visits varies by symptom presentation, routinely offered and accepted telehealth visits appear to lead to near-term symptom outcomes similar to in-person visits.
PMID:
42723499
Bibliographic data and abstract were imported from PubMed on 11 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0